Exploring how blood vessel damage affects breathing difficulties in patients with acute respiratory distress syndrome.
Investigating the Role of Vascular Injury and Physiologic Dead Space in the Acute Respiratory Distress Syndrome
This study is looking at how damage to blood vessels affects breathing problems in people with acute respiratory distress syndrome (ARDS) and aims to find better ways to treat this serious condition by checking certain blood markers.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Los Angeles NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project ID | NIH-11004968 on NIH RePORTER |
What this research studies
This research investigates the role of vascular injury in acute respiratory distress syndrome (ARDS), a serious condition that affects breathing. The project aims to understand how damage to blood vessels contributes to lung dysfunction and worsens patient outcomes. By measuring specific blood markers, the research seeks to assess the severity of pulmonary disease and improve treatment strategies. The principal investigator, Dr. Ana Monteiro, will utilize advanced techniques in data analysis and transcriptomics to enhance understanding of ARDS.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults diagnosed with acute respiratory distress syndrome.
Not a fit: Patients with chronic respiratory conditions unrelated to acute respiratory distress syndrome may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnostic and treatment options for patients suffering from acute respiratory distress syndrome.
How similar studies have performed: Previous research has shown promising results in understanding vascular injury's role in respiratory conditions, indicating that this approach has potential for significant insights.
Where this research is happening
Los Angeles, United States
- University of California Los Angeles — Los Angeles, United States (Active)
Researchers
- Principal investigator: Costa Monteiro, Ana Carolina — University of California Los Angeles
- Study coordinator: Costa Monteiro, Ana Carolina
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.